Logo

FINANCIAL INFORMATION

Definitions

This report contains financial key ratios in accordance with the frameworks applied by AddLife, which are based on IFRS. In addition, there are other key ratios (alternative performance measures) that cannot be directly obtained from or derived from the financial statements. These key figures are central to understand and evaluate AddLifes business and financial position. They should not be viewed as a replacement for the measures defined under IFRS, but rather as a complement to the financial reporting. Since not all companies calculate financial measures in the same way, these are not always comparable with measures used by other companies. The key figures are presented in the Multi-year overview and commented on in the administration report. The key figures that are the financial targets are commented in the section "Financial targets".

 

Return on equity


Profit/loss after tax attributable to shareholders, as a percentage of shareholders' proportion of average equity.
Return on equity measures from an ownership perspective the return that is given on the owners' invested capital.

  2025 2024
Profit for the year attributable to the shareholders 560 252
Average equity 5,288 5,146
Return on equity, % 11 5

Return on working capital (P/WC)


EBITA in relation to average working capital.
P/WC is used to analyse profitability and encourage high EBITA earnings and low working capital requirements.

  2025 2024
EBITA 1,417 1,159
Working capital, average 2,286 2,284
Return on working capital, % 62 51

Return on capital employed


Profit after net financial items plus interest expenses plus/minus exchange rate fluctuations in percent of average capital employed.
Return on capital employed is an indication of the Group’s efficiency in its use of capital resources.

  2025 2024
Profit/loss before taxes 772 405
Interest expenses 202 300
Net exchange rate fluctuations 10 0
Profit after net financial items plus interest expenses and net foreign exchange differences 984 705
Capital employed, average 10,317 10,645
Return on capital employed, % 10 7

EBITA / EBITA margin


Operating profit before amortization of intangible assets.
EBITA is used to analyse profitability generated by operational activities.

EBITA as a percentage of net sales.
The EBITA margin is used to analyze value creation from the operating activities.

  2025 2024
Operating profit 993 721
Amortization and impairment of intangible assets 424 438
EBITA 1,417 1,159
Net sales 10,442 10,286
EBITA margin, % 13.6 11.3

Adjusted EBITA / Adjusted EBITA margin


EBITA excluding one-off costs.
Increases the comparability of EBITA over time as it is adjusted for the impact of items considered to be non-recurring in nature and therefore do not reflect the underlying operations.

Adjusted EBITA in relation to net sales.
Used to measure the company's profitability excluding the impact of items considered to be non-recurring in nature and therefore do not reflect the underlying operations.

  2025 2024
EBITA 1,417 1,159
One-off costs    
Restructuring reserve Camanio 10
Revalued contingent consideration -4
Divestment of operations -158
Adjusted EBITA 1,259 1,165
Net sales 10,442 10,286
Adjusted EBITA margin, % 12.1 11.3

EBITDA


Operating profit before depreciation, amortization and write-down.
EBITDA is used to analyse profitability generated by operational activities.

  2025 2024
EBITA 1,417 1,159
Depreciation and impairment of tangible assets 385 374
EBITDA 1,802 1,533

One-off costs


Primarily refers to restructuring costs and revaluation of contingent considerations. Other non-recurring items may also be reported as one-off costs if this provides a more accurate view of the underlying operating result.

  2025 2024
Restructuring reserve Camanio -10
Revalued contingent consideration 4
Divestment of operations 158
One-off costs 158 -6

Organic growth


Changes in net sales excluding currency effects and acquisitions/divestments compared to the same period the previous year.
Organic growth is used to analyze the underlying sales growth driven by changes in volume, product range, and price for similar products between different periods.

  Labtech   Medtech   Group¹
% 2025 2024   2025 2024   2025 2024
Total growth 4.1 4.0   0.0 7.5   1.5 6.2
(-) Currency effect -2.7 -0.5   -3.2 0.2   -3.0 -0.1
(-) Acquired growth 1.4 1.6   1.0   1.1 0.6
Organic growth 5.4 2.9   2.2 7.3   3.4 5.7
                 
  Labtech   Medtech   Group¹
  2025 2024   2025 2024   2025 2024
Total growth 156 145   -1 454   156 601
(-) Currency effect -101 -20   -208 11   -310 -10
(-) Acquired growth 53 57   64   118 57
Organic growth 204 108   143 443   348 554
¹The Group includes eliminations                

Equity per share


Shareholders' proportion of equity divided by the number of shares outstanding at the end of the reporting period. 

  2025 2024
Shareholders' proportion of equity 5,443 5,306
Number of shares outstanding at the end of the financial year, 000 121,864 121,864
Equity per share, SEK 44.67 43.54

Cash flow per share


Cash flow from operating activities, divided by the average number of shares.

  2025 2024
Cash flow from operating activities 1,392 1,095
Average number of shares, ’000 121,864 121,863
Cash flow per share, SEK 11.42 8.98

Earnings per share


Shareholders' share of the period's result divided by the number of shares outstanding at the end of the reporting period.
Earnings per share is used to determine the value of the company’s weighted average number of outstanding common shares.

  2025 2024
Shareholders’ share of the profit for the year 560 252
Average number of shares, ’000 121,864 121,863
Earnings per share before dilution, SEK 4.59 2.06
     
Average number of shares after dilution, ’000 121,864 121,863
Earnings per share after dilution, SEK 4.59 2.06

Profit growth EBITA / Profit growth adjusted EBITA


Current year’s EBITA/adjusted EBITA minus previous year’s EBITA/adjusted EBITA, divided by previous year’s EBITA/adjusted EBITA.
Proft growth EBITA/adjusted EBITA is used to analyse asset-creating generated from operational activities.

  2025 2024
EBITA 1,417 1,159
Previous year's EBITA -1,159 -1,135
EBITA growth 258 24
Profit growth adjusted EBITA, % 22 2
     
Adjusted EBITA 1,259 1,165
Previous year's adjusted EBITA -1,165 -1,015
Adjusted EBITA growth 94 150
Profit growth adjusted EBITA, % 8 14

Financial net liabilities and Net debt/equity ratio


Interest-bearing liabilities and interest-bearing provisions, less cash and cash equivalents.
Net debt is used to monitor debt development and analyse financial leverage and any necessary refinancing.

Financial net liabilities in relation to shareholders’ equity.
Net debt/equity ratio is used to analyse financial risk.

  2025 2024
Borrowing 4,146 4,434
Cash and cash equivalents -813 -331
Financial net debt 3,333 4,103
Pension liability 58 62
Lease liability 504 531
Contingent considerations 124 106
Provisions 29 118
Net interest-bearing debt 4,048 4,920
Shareholder's equity 5,447 5,309
Net debt/equity ratio, multiple 0.7 0.9

Financial net liabilities/EBlTDA


Financial net liabilities divided by EBITDA.
Financial net liabilities compared with EBITDA provides a key financial indicator for financial net liabilities in relation to cash-generated operating profit; i.e., an indication of the ability of the business to pay its debts. This measure is generally used by financial institutions as a measure of creditworthiness.

  2025 2024
Net interest-bearing debt 4,048 4,920
EBITDA 1,802 1,533
Financial net liabilities/EBITDA, multiple 2.2 3.2

Interest coverage ratio


EBITDA in relation to interest expenses.

  2025 2024
EBITDA 1,802 1,533
Interest expenses 202 300
Interest coverage ratio, multiple 8.9 5.1

Working capital


Sum of inventories and accounts receivable, less accounts payable. In the calculation of P/WC, average working capital is used.
Working capital is used to analyse how much working capital is tied up in the business.

  2025 2024
Inventories, average 1,713 1,743
Accounts receivable, average 1,586 1,537
Accounts payable, average -1,013 -996
Working capital, average 2,286 2,284

Operating margin


Operating profit as a percentage of net sales.

  2025 2024
Operating profit 993 721
Net sales 10,442 10,286
Operating margin, % 9.5 7.0

Equity ratio


Equity including minority interest as a percentage of total assets.
The equity ratio is used to analyse financial risk and shows how much of the assets are financed with equity.

  2025 2024
Shareholder's equity 5,447 5,309
Total assets 12,711 13,055
Equity ratio, % 43 41

Debt/equity ratio


Interest-bearing liabilities and interest-bearing provisions in relation to equity.

  2025 2024
Non-current interest-bearing liabilities 2,831 4,092
Provisions for pensions 58 62
Interest-bearing provisions 29 118
Current interest-bearing liabilities 1,943 979
Interest-bearing liabilities and provisions 4,861 5,251
Shareholder's equity 5,447 5,309
Debt/equity ratio, multiple 0.9 1.0

Capital employed


Total assets less non-interest-bearing liabilities and provisions.

  2025 2024
Deferred tax liabilities 324 374
Accounts payable 1,047 1,098
Tax liabilities 110 69
Other liabilities 386 369
Accrued expenses and deferred income 485 531
Provisions 51 141
Non-interest-bearing liabilities and provisions 2,403 2,582
     
Total assets 12,711 13,055
Non-interest-bearing liabilities and provisions -2,403 -2,582
Capital employed 10,308 10,473

Profit margin


Profit before taxes in percentage of net sales.

  2025 2024
Profit/loss before taxes 772 405
Net sales 10,442 10,286
Profit margin, % 7.4 3.9

Loading...